Inhibition of matrix metalloproteinases-2 and -9 prevents cognitive impairment induced by pneumococcal meningitis in Wistar rats
- PMID: 24419461
- DOI: 10.1177/1535370213508354
Inhibition of matrix metalloproteinases-2 and -9 prevents cognitive impairment induced by pneumococcal meningitis in Wistar rats
Abstract
Pneumococcal meningitis is a relevant clinical disease characterized by an intense inflammatory reaction into the subarachnoid and ventricular spaces, leading to blood-brain barrier breakdown, hearing loss, and cognitive impairment. Matrix metalloproteinases (MMPs) are capable of degrading components of the basal laminin, thus contributing to BBB damage and neuronal injury. In the present study, we evaluated the effects of MMP-2, MMP-9, and MMP-2/9 inhibitors on BBB integrity, learning, and memory in Wistar rats subjected to pneumococcal meningitis. The animals underwent a magna cistern tap and received either 10 µL sterile saline as a placebo or an equivalent volume of a Streptococcus pneumoniae suspension at a concentration of 5 × 10(9)cfu/mL. The rats were randomized into different groups that received adjuvant treatment with MMP-2, MMP-9 or MMP-2/9 inhibitors. The BBB integrity was evaluated, and the animals were habituated to open-field and object recognition tasks 10 days after meningitis induction. Adjuvant treatments with inhibitors of MMP-2 or MMP-2/9 prevented BBB breakdown in the hippocampus, and treatments with inhibitors of MMP-2, MMP-9 or MMP-2/9 prevented BBB breakdown in the cortex. Ten days after meningitis induction, the animals that received adjuvant treatment with the inhibitor of MMP-2/9 demonstrated that animals habituated to the open-field task faster and enhanced memory during short-term and long-term retention test sessions in the object recognition task. Further investigation is necessary to provide support for MMP inhibitors as an alternative treatment for bacterial meningitis; however, these findings suggest that the meningitis model could be a good research tool for studying the biological mechanisms involved in the behavioral alterations associated with pneumococcal meningitis.
Keywords: Meningitis; Streptococcus pneumoniae; blood–brain barrier; learning and memory; metalloproteinases-2 and 9.
Similar articles
-
Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis.Eur J Pharmacol. 2012 Dec 15;697(1-3):158-64. doi: 10.1016/j.ejphar.2012.09.053. Epub 2012 Oct 16. Eur J Pharmacol. 2012. PMID: 23085269
-
Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis.Brain Res. 2008 May 1;1207:237-43. doi: 10.1016/j.brainres.2008.01.106. Epub 2008 Mar 4. Brain Res. 2008. PMID: 18374903
-
Inhibition of indoleamine 2,3-dioxygenase prevented cognitive impairment in adult Wistar rats subjected to pneumococcal meningitis.Transl Res. 2013 Dec;162(6):390-7. doi: 10.1016/j.trsl.2013.08.001. Epub 2013 Aug 28. Transl Res. 2013. PMID: 23994082
-
Targets for adjunctive therapy in pneumococcal meningitis.J Neuroimmunol. 2015 Jan 15;278:262-70. doi: 10.1016/j.jneuroim.2014.11.015. Epub 2014 Nov 20. J Neuroimmunol. 2015. PMID: 25468775 Review.
-
Experimental studies of pneumococcal meningitis.Dan Med Bull. 2010 Jan;57(1):B4119. Dan Med Bull. 2010. PMID: 20175949 Review.
Cited by
-
The blood-brain barrier in Alzheimer's disease.Neurobiol Dis. 2017 Nov;107:41-56. doi: 10.1016/j.nbd.2016.07.007. Epub 2016 Jul 15. Neurobiol Dis. 2017. PMID: 27425887 Free PMC article. Review.
-
Serum Level of MMP-3 and MMP-9 in Patients with Diabetes Mellitus Type 2 Infected with Epstein-Barr Virus.Int J Mol Sci. 2022 Nov 6;23(21):13599. doi: 10.3390/ijms232113599. Int J Mol Sci. 2022. PMID: 36362386 Free PMC article.
-
Effects of Mesenchymal Stem Cell Treatment on the Expression of Matrix Metalloproteinases and Angiogenesis during Ischemic Stroke Recovery.PLoS One. 2015 Dec 4;10(12):e0144218. doi: 10.1371/journal.pone.0144218. eCollection 2015. PLoS One. 2015. PMID: 26637168 Free PMC article.
-
Is there new hope for therapeutic matrix metalloproteinase inhibition?Nat Rev Drug Discov. 2014 Dec;13(12):904-27. doi: 10.1038/nrd4390. Epub 2014 Nov 7. Nat Rev Drug Discov. 2014. PMID: 25376097 Review.
-
Role of Matrix Metalloproteinases in the Pathogenesis of Traumatic Brain Injury.Mol Neurobiol. 2016 Nov;53(9):6106-6123. doi: 10.1007/s12035-015-9520-8. Epub 2015 Nov 5. Mol Neurobiol. 2016. PMID: 26541883 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous